Bahram Resul

Bahram Resul (born 1945) is a Kurdish medical chemist, inventor and the founding CEO of Awamedica. Resul has a PhD in Medicinal Chemistry from Uppsala University, where he is now an associate professor.[1]

Resul invented Latanoprost along with Swedish chemist Johan W. Stjernschantz. Latanoprost is a medication used to treat glaucoma,[2] as the head of the Medicinal Chemistry Department of Pharmacia Ophthalmics, a pharmaceuticals firm in Sweden.

See also

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.